The Use of Cyclosporine for Recurrent Hepatitis C After Liver Transplant: a Randomized Pilot Study Academic Article uri icon

abstract

  • Cyclosporine has antiviral activity in vitro against hepatitis C (HCV). We performed a pilot study to prospectively determine the antiviral effect of cyclosporine during therapy with PEGalfa-2a and ribavirin in liver transplant recipients with recurrent HCV infection.

publication date

  • 2010-01-01